[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356625-105":59,"doc-detail-356625-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","integrating-circulating-micrornas-with-epidemiological-factors-enhances-breast-cancer-detection-across-subtypes-the-mcc-spain-study","Integrating circulating microRNAs with epidemiological factors enhances breast cancer detection across subtypes - the MCC-Spain study","","Circulating microRNAs (miRNAs) offer promising non-invasive biomarkers for cancer detection, yet their diagnostic value across breast cancer molecular subtypes and beyond demographic and epidemiological variables remains insufficiently defined. A multicenter case-control study analyzed 317 breast cancer cases and 127 population-based controls, quantifying 44 literature-derived serum miRNAs by RT-qPCR and selecting features via LASSO. Multivariable logistic models with repeated fivefold cross-validation showed that adding demographic and epidemiological covariates improved discrimination overall (AUC 0.908 vs 0.802) and across subtypes.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-circulating-micrornas-with-epidemiological-factors-enhances-breast-cancer-detection-across-subtypes-the-mcc-spain-study/356625/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-circulating-micrornas-with-epidemiological-factors-enhances-breast-cancer-detection-across-subtypes-the-mcc-spain-study/356625.png","ImageObject",300,407,{"name":92,"@type":93},"Maya Linwood","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the MCC-Spain study?","Question",{"text":112,"@type":113},"To evaluate whether circulating microRNAs improve breast cancer detection across molecular subtypes and whether their added value persists beyond demographic and epidemiological factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were miRNAs measured and selected for modeling?",{"text":117,"@type":113},"Serum levels of 44 literature-derived miRNAs were quantified using RT-qPCR, then feature selection used LASSO penalization before logistic regression.",{"name":119,"@type":110,"acceptedAnswer":120},"What effect did demographic and epidemiological covariates have on diagnostic performance?",{"text":121,"@type":113},"Including these covariates increased discrimination overall (AUC 0.908 vs 0.802) and improved performance particularly in Luminal A and Luminal B subtypes.",{"name":123,"@type":110,"acceptedAnswer":124},"Which miRNAs were most consistently different between cases and controls?",{"text":125,"@type":113},"Among LASSO-selected miRNAs, miR-21-5p and miR-423-3p were consistently elevated in cases, while miR-101-3p, miR-146a-5p, and miR-29a-3p showed reproducibly lower levels across multiple subtypes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},356625,1790165692,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":36,"preview_page_count":19,"preview_urls":149},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIntegrating circulating microRNAs with epidemiological factors enhances breast cancer detection across subtypes: the MCC-Spain study  \nInés Gómez-Acebo1,2,3,20􀀍, Sara Valero-Dominguez1,2,20, Javier Llorca1,  \nJessica Alonso-Molero1,2,3, Thalía Belmonte4, Gemma Castaño-Vinyals3,5,6,7, Víctor Moreno3,8,9,10, Aina Romaguera11,12, Pilar Amiano3,13, Juan Alguacil3,14, Vicente Martín15, Beatriz Pérez-Gómez3,16, Rosana Burgui3,17, Ana Molina-Barceló18, Paz Rodríguez-Cundín19, Manolis Kogevinas3,5,6,7, Marina Pollán3,16 &  \nTrinidad Dierssen-Sotos1,2,3  \nCirculating microRNAs (miRNAs) are promising non-invasive biomarkers for cancer detection; however, their diagnostic performance across breast cancer molecular subtypes and their incremental value beyond demographic and epidemiological variables remain incompletely characterized. We conducted a multicenter case–control study including 317 breast cancer cases and 127 populationbased controls. Serum levels of 44 literature-derived miRNAs were quantified by RT-qPCR. Featureselection was performed using LASSO penalization, followed by multivariable logistic regression to estimate odds ratios (ORs) with 95% confidence intervals (CIs) . Models were adjusted for demographic and epidemiological covariates. Predictive performance was assessed using repeated fivefold  \ncross-validation and reported as area under the curve (AUC) with bootstrap bias-corrected 95%  \nCIs. Incorporating demographic and epidemiological covariates enhanced discrimination overall (AUC = 0.908 vs. 0.802 unadjusted) and across subtypes. The most notable improvements were observed in LuminalA (0.896 vs. 0.751) and Luminal B (0.894 vs. 0.768), while HER2-positive and Basal-like tumors already showed high performance (AUC = 0.965 and 0.989, respectively). Among the 12 miRNAs selected by LASSO, miR-21-5p and miR-423-3p were consistently elevated in cases, particularly in HER2-positive and Basal-like tumors, whereas miR-101-3p, miR-146a-5p, and miR- 29a-3p showed reproducibly lower levels across multiple subtypes, consistent with oncogenic and tumor-suppressive roles, respectively. Circulating miRNA signatures, especially when integrated with demographic and epidemiological information, demonstrate high discriminatory power for breast cancer detection across molecular subtypes. These results support subtype-aware, minimally invasive strategies for screening and risk stratification using miRNA-based models. Prospective validation in independent cohorts is warranted to confirm clinical utility.  \nKeywords Breast cancer, Molecular subtypes, Circulating miRNA, LASSO, ROC-AUC, Risk stratification  \n1Department of Preventive Medicine and Public Health, University of Cantabria, Santander, Spain. 2IDIVAL-Valdecilla Health Research Institute, Santander, Spain. 3Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain. 4Instituto de Investigación Sanitaria del Principadode Asturias, Oviedo, Spain. 5Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. 6Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain. 7Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. 8Colorectal Cancer Group, ONCOBELL Program, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. 9Oncology Data Analytics Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain. 10Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona, Barcelona, Spain. 11Josep Carreras Leukaemia Research Institute, Badalona, Spain. 12Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government  \n[www. nature.com/scientificreports/](www. nature","cbCais3zm1mAqIWj","https://ap.wps.com/l/cbCais3zm1mAqIWj","pdf",1795128,16,"English","# Integrating circulating microRNAs with epidemiological factors enhances breast cancer detection across subtypes\n## Study design and participants\n## miRNA measurement and feature selection\n## Predictive modeling and validation\n## Results across molecular subtypes\n## Selected miRNAs and biological interpretation\n## Implications and next steps","[{\"question\":\"What was the main goal of the MCC-Spain study?\",\"answer\":\"To evaluate whether circulating microRNAs improve breast cancer detection across molecular subtypes and whether their added value persists beyond demographic and epidemiological factors.\"},{\"question\":\"How were miRNAs measured and selected for modeling?\",\"answer\":\"Serum levels of 44 literature-derived miRNAs were quantified using RT-qPCR, then feature selection used LASSO penalization before logistic regression.\"},{\"question\":\"What effect did demographic and epidemiological covariates have on diagnostic performance?\",\"answer\":\"Including these covariates increased discrimination overall (AUC 0.908 vs 0.802) and improved performance particularly in Luminal A and Luminal B subtypes.\"},{\"question\":\"Which miRNAs were most consistently different between cases and controls?\",\"answer\":\"Among LASSO-selected miRNAs, miR-21-5p and miR-423-3p were consistently elevated in cases, while miR-101-3p, miR-146a-5p, and miR-29a-3p showed reproducibly lower levels across multiple subtypes.\"}]","Integrating circulating microRNAs with epidemiological factors enhances breast cancer detection across subtypes - the MCC-Spain study | PDF",1790126386,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/767d83cf4e09c0e9d585dcbfbb97971c.webp",983,1291,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c80aaa21134993f255c199de0506b87.webp",982,1290,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b06bae49ec744f01b084c66a9753b2b.webp",981,1289,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/596d840281005d7ca05fe28ac1c37905.webp",980,1287]